Protalix Biotherapeutics Inc (AMEX:PLX) had its price target hoisted by Rodman & Renshaw from $4.00 to $5.00 in a research report report published on Monday. They currently have a buy rating on the stock.

Protalix Biotherapeutics (AMEX:PLX) opened at 1.00 on Monday. The firm has a 50-day moving average of $1.18 and a 200 day moving average of $0.72. The firm’s market capitalization is $124.13 million. Protalix Biotherapeutics has a 12-month low of $0.26 and a 12-month high of $1.51.

TRADEMARK VIOLATION WARNING: “Rodman & Renshaw Boosts Protalix Biotherapeutics Inc (PLX) Price Target to $5.00” was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright legislation. The legal version of this piece of content can be read at https://www.watchlistnews.com/rodman-renshaw-boosts-protalix-biotherapeutics-inc-plx-price-target-to-5-00/1206274.html.

Receive News & Ratings for Protalix Biotherapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Protalix Biotherapeutics Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.